David Joseph Topper insider trades

Open-market stock purchases and sales by David Joseph Topper, Chief Financial Officer at Arcutis Biotherapeutics, Inc, from SEC Form 4 filings since Nov 22, 2022.

Recent trades

No open-market trades in the last 12 months.

Companies traded

ARQT Arcutis Biotherapeutics, Inc: 2 sales, last Apr 2, 2025
FLAC Frazier Lifesciences Acquisition Corp: other filings, last Nov 22, 2022

Get free alerts when David Joseph Topper files a new trade →